Mark A. LaPack
Mark A. LaPack is research advisor, Small Molecule Design & Development, Eli Lilly and Company.
Articles
A Biopharmaceutical Industry Perspective on Single-Use Sensors for Biological Process Applications
Mark A. LaPack;Tony Y. Wang;Michael C. Brandenstein;Stacey M. Kaneshiro;Victor M. Saucedo;Seongkyu Yoon;Robert E. Kottmeier;Yuk Chun Chiu;Bradley H. Diehl;Yongchun Zhang
April 1st 2015This article presents first-hand perspectives from industry users to suppliers of single-use sensors.
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: December 9th 2024 | Updated: December 22nd 2024
Recap Key Industry Trends for Viral Clearance and NGS
Published: December 7th 2024 | Updated: December 22nd 2024
Enhancing Quality Through Training
Published: July 20th 2020 | Updated: December 22nd 2024
Contact BioPharm International Editors
Published: July 19th 2020 | Updated: December 22nd 2024
Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars
